Agios Pharma (AGIO) Reports Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 37.19 +0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.18 | 52 Week High | $71.49 | |||
| Open | $37.22 | 52 Week Low | $33.50 | |||
| Day High | $37.74 | P/E | N/A | |||
| Day Low | $36.35 | EPS | $-1.18 | |||
| Volume | 931,100 | |||||
